King Abdulaziz Hospital in Jeddah launches ‘Together for Better Health’ campaign, emphasising early detection and lifestyle changes to combat diabetes, hypertension, and obesity amid rising chronic illness rates. The Diabetes and Endocrinology Centre at King Abdulaziz Hospital in Jeddah has…
A routine check in the seventh month uncovered dangerously high blood sugar levels in a high-risk pregnant woman, highlighting the importance of screening for gestational diabetes that often shows few or no symptoms but poses serious risks to mother and…
Gestational diabetes often presents no obvious symptoms, making routine screening vital to prevent risks for mother and baby. Experts highlight how early detection through standard testing can ensure better outcomes for both. Gestational diabetes can arrive quietly in pregnancy, which…
A recent six-month trial from the University of Illinois Chicago indicates that limiting eating to an eight-hour window could help adults with type 1 diabetes and obesity manage blood sugar levels more effectively without immediate safety concerns, though further research…
Sudden, unexplained weight loss accompanied by thirst and fatigue may signal the onset of diabetes. Health authorities emphasise the importance of early recognition to prevent serious complications. Sudden, unintentional weight loss can be a warning sign of diabetes, particularly when…
Fresh filings reveal several institutional investors, including Man Group, are building new positions in DexCom as the FDA broadens access to its Stelo glucose sensor for children, intensifying competition in the growing continuous glucose monitoring sector. DexCom is drawing renewed…
The University of Florida Diabetes Institute launches an on-campus screening event at the Plaza of the Americas, aiming to detect Type 1 diabetes early among students and complement ongoing education and support efforts. The University of Florida Diabetes Institute has…
The University of Florida Diabetes Institute launched a campus-based screening event and broader programme to enhance early detection of type 1 diabetes, integrating AI, outreach, and research to prevent serious complications. The University of Florida Diabetes Institute held an on-campus…
A recent study challenges longstanding beliefs by pinpointing the intestine as the main target of metformin’s glucose-lowering effects, offering fresh perspectives on its mechanism and potential for personalised treatment. For decades, metformin has been the first-line medicine for many people…
Emerging research suggests that red and near-infrared light therapy could aid glucose control and reduce insulin resistance, but experts emphasise that further studies are essential before widespread clinical adoption. Red light therapy is being promoted as more than a recovery…
